Loading...
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
OBJECTIVE: To evaluate the safety and efficacy of cholecalciferol in patients with relapsing-remitting MS (RRMS). METHODS: In this double-blind, placebo-controlled parallel-group, 2-year study, 181 patients with RRMS were randomized 1:1. Key inclusion criteria were a low serum 25-hydroxy vitamin D (...
Na minha lista:
| Udgivet i: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6705622/ https://ncbi.nlm.nih.gov/pubmed/31454777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000597 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|